Pancreatic Cancer

>

CURE’s pancreatic cancer page features the latest cancer news and updates on pancreatic cancer Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in pancreatic cancer.

Latest News

Daraxonrasib has received breakthrough therapy designation from the FDA for KRAS G12+, previously treated, metastatic PDAC: © stock.adobe.com.
Daraxonrasib Gains FDA Status for Certain Metastatic Pancreatic Cancer

June 24th 2025

Daraxonrasib has received breakthrough therapy designation from the FDA for KRAS G12+, previously treated, metastatic pancreatic ductal adenocarcinoma.

Image of Tripp
Spotlighting Pancreatic Cancer Disparities in Black Communities

June 23rd 2025

Atebimetinib with modified chemo led to 94% 6-month survival rates in first-line pancreatic cancer: © stock.adobe.com.
Atebimetinib Combo Shows 94% 6-Month Survival in Pancreatic Cancer

June 18th 2025

William Ramshaw resides in the expansive Pacific Northwest. He is a six-year survivor of pancreatic cancer. Catch up on William’s blogs here!
Pancreatic Cancer Tried to Crash My Three Daughters’ Weddings

June 13th 2025

From left: GAYLE S. JAMESON, M.S.N, ACNP-BC, AOCN, and ERIN PIERCE, M.S.N., APRN, FNP-C; PHOTOS BY AZULA RAUN
A Trailblazer in Oncology Nursing and Research

May 21st 2025

More News